Medtronic’s growth drivers
14/03/2025
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, said Medtronic’s CEO Geoff Martha at
Keeping your diabetes kit safe and in one place.
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, said Medtronic’s CEO Geoff Martha at
Vertex has presented new data on its clinical trial VX-880, hailed as a potentially revolutionary treatment for people with Type 1
The University of Liverpool’s AI diagnostic technology spin-out, AI-Sight, has successfully concluded its seven-figure equity funding round from experienced healthcare industry
This issue feels a little heavy, as a few topics are tough ones, about people feeling stigma, shame or simply experiencing
New research has showed that the majority of patients achieving high rates of glucose control and weight loss in the first
Sheffield Teaching Hospitals NHS Foundation Trust has launched a trial utilising smart technologies with the aim of reversing the risk of
